Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations

  • A. Peron*
  • , F. D'Arco
  • , K. A. Aldinger
  • , C. Smith-Hicks
  • , C. Zweier
  • , G. A. Gradek
  • , K. Bradbury
  • , A. Accogli
  • , E. F. Andersen
  • , P. Y. B. Au
  • , R. Battini
  • , D. Beleford
  • , L. M. Bird
  • , A. Bouman
  • , Bruel A. -L.
  • , O. L. Busk
  • , P. M. Campeau
  • , V. Capra
  • , C. Carlston
  • , J. Carmichael
  • A. Chassevent, J. Clayton-Smith, M. J. Bamshad, D. L. Earl, L. Faivre, C. Philippe, P. Ferreira, L. Graul-Neumann, M. J. Green, D. Haffner, P. Haldipur, S. Hanna, G. Houge, W. D. Jones, C. Kraus, B. E. Kristiansen, J. Lespinasse, K. J. Low, S. A. Lynch, S. Maia, R. Mao, R. Kalinauskiene, C. Melver, K. McDonald, T. Montgomery, M. Morleo, C. Motter, A. S. Openshaw, J. C. Palumbos, A. S. Parikh, Y. Perilla-Young, C. M. Powell, R. Person, M. Desai, J. Piard, R. Pfundt, M. Scala, M. Serey-Gaut, D. Shears, A. Slavotinek, M. Suri, C. Turner, T. Tvrdik, K. Weiss, I. M. Wentzensen, Marcella Zollino, Hsieh T. -C., K. Ramsey, Marcella Zollino, M. Scala, V. Capra, A. Peron*, B. B. A. de Vries, F. Guillemot, W. B. Dobyns, D. Viskochil, C. Dias*
*Autore corrispondente per questo lavoro
  • Fondazione Telethon
  • University of Utah
  • Azienda Ospedaliero Universitaria Meyer
  • University of Florence
  • Johns Hopkins University
  • Kennedy Krieger Institute
  • Friedrich-Alexander University Erlangen-Nürnberg
  • University of Bern
  • Guy’s & St Thomas’ NHS FT
  • Princess Anne Hospital
  • IRCCS Istituto Giannina Gaslini - Genova
  • University of Pisa
  • IRCCS Fondazione Stella Maris - Calambrone (Pisa)
  • University of California at San Francisco
  • University of California at Davis
  • Erasmus Medical Center
  • Boston Children's Hospital
  • Cambridge University Hospitals NHS Foundation Trust
  • School of Dentistry
  • Manchester University NHS Foundation Trust
  • Lipides, Nutrition, Cancer - LNC
  • INSERM Unité Mixte de Recherche (UMR) 1231
  • University of Calgary
  • Charité – Universitätsmedizin Berlin
  • Center for Microbial Pathogenesis
  • Seattle Children’s Research Institute
  • Technion-Israel Institute of Technology
  • Rambam Health Care Campus Israel
  • University of Bergen
  • Centre Hospitalier Métropole Savoie
  • University of Coimbra
  • Akron Children's Hospital
  • University of Mississippi
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • University of Campania Luigi Vanvitelli
  • University of North Carolina at Chapel Hill
  • OPKO Health, Inc.
  • Radboud University Nijmegen
  • Université Paris Cité
  • Oxford University Hospitals NHS Foundation Trust
  • University of Cincinnati
  • Nottingham University Hospitals NHS Trust
  • Royal Devon & Exeter NHS Foundation Trust
  • Emory University
  • Translational Genomics Research Institute
  • The Francis Crick Institute
  • Great Ormond Street Hospital for Children
  • Faculty of Life Sciences & Medicine

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

An increasing number of individuals with intellectual developmental disorder (IDD) and heterozygous variants in BCL11A are identified, yet our knowledge of manifestations and mutational spectrum is lacking. To address this, we performed detailed analysis of 42 individuals with BCL11A-related IDD (BCL11A-IDD, a.k.a. Dias-Logan syndrome) ascertained through an international collaborative network, and reviewed 35 additional previously reported patients. Analysis of 77 affected individuals identified 60 unique disease-causing variants (30 frameshift, 7 missense, 6 splice-site, 17 stop-gain) and 8 unique BCL11A microdeletions. We define the most prevalent features of BCL11A-IDD: IDD, postnatal-onset microcephaly, hypotonia, behavioral abnormalities, autism spectrum disorder, and persistence of fetal hemoglobin (HbF), and identify autonomic dysregulation as new feature. BCL11A-IDD is distinguished from 2p16 microdeletion syndrome, which has a higher incidence of congenital anomalies. Our results underscore BCL11A as an important transcription factor in human hindbrain development, identifying a previously underrecognized phenotype of a small brainstem with a reduced pons/medulla ratio. Genotype-phenotype correlation revealed an isoform-dependent trend in severity of truncating variants: those affecting all isoforms are associated with higher frequency of hypotonia, and those affecting the long (BCL11A-L) and extra-long (-XL) isoforms, sparing the short (-S), are associated with higher frequency of postnatal microcephaly. With the largest international cohort to date, this study highlights persistence of fetal hemoglobin as a consistent biomarker and hindbrain abnormalities as a common feature. It contributes significantly to our understanding of BCL11A-IDD through an extensive unbiased multi-center assessment, providing valuable insights for diagnosis, management and counselling, and into BCL11A’s role in brain development.
Lingua originaleInglese
pagine (da-a)N/A-N/A
RivistaEuropean Journal of Human Genetics
Numero di pubblicazioneN/A
DOI
Stato di pubblicazionePubblicato - 2024

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

  • Genetica
  • Genetica (clinica)

Keywords

  • BCL11A-Related Intellectual Disability

Fingerprint

Entra nei temi di ricerca di 'BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations'. Insieme formano una fingerprint unica.

Cita questo